ArticleFrontiers in human neuroscience2026
ScaleSpecter: a frequency-aware multi-scale patch framework for robust physiological classification under non-stationarity.
Article in Frontiers in human neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Early detection and intervention for cognitive impairment associated with neurodegenerative diseases are important for slowing disease progression and improving quality of life. Electroencephalography provides high temporal resolution and sensitivity to neural oscillations, making it a promising tool for early disease identification. However, weak and transient pathological abnormalities are often obscured by diffuse, non-stationary low-frequency background rhythms, making robust feature extraction challenging. Methods: We propose ScaleSpecter, a frequency-aware multiscale patch framework for neurodegenerative disease-related EEG classification. ScaleSpecter first constructs temporal representations at multiple scales to jointly capture transient local abnormalities and long-term rhythmic variations. A lightweight cross-scale attention mechanism then enables interaction between fine-grained temporal tokens and coarse scale-level summaries. Finally, an amplitude-phase-aware spectral modulation module uses learnable complex-valued weights to recalibrate spectral responses and provide frequency-domain guidance for temporal feature aggregation. Results: Extensive experiments were conducted on three public EEG datasets: the Alzheimer's Disease and Frontotemporal Dementia (ADFTD) dataset, the Alzheimer's Patients' Relatives Association of Valladolid (APAVA) dataset, and the Two Decades-Brainclinics Research Archive for Insights in Neurophysiology (TDBRAIN) database. These datasets cover classification tasks related to Alzheimer's disease, frontotemporal dementia, and Parkinson's disease. ScaleSpecter achieved competitive and generally favorable performance on most key evaluation metrics. The ablation and visualization results further demonstrated the complementary contributions of multiscale temporal modeling, cross-scale interaction, and spectral modulation. Discussion: The results suggest that integrating frequency-domain guidance with multiscale temporal representations can improve the discriminative capability and robustness of EEG classification under non-stationary conditions. ScaleSpecter provides a potentially generalizable framework for neurodegenerative disease-related physiological signal analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.